A neonate with mucolipidosis II and transient secondary hyperparathyroidism

J Pediatr Endocrinol Metab. 2019 Dec 18;32(12):1399-1402. doi: 10.1515/jpem-2019-0162.

Abstract

Background Mucolipidosis II α/β (ML II) is an autosomal recessive disease associated with the abnormality of lysosomal enzyme trafficking. Case presentation We present an unusual patient with: (a) marked skeletal anomalies with secondary hyperparathyroidism; (b) serum intact parathyroid hormone level normalized by 7 weeks but abnormally elevated serum alkaline phosphate persisted; and (c) two mutations identified in the GNPTAB gene. One mutation, c.3503_3504delTC, is the most common mutation in ML II. However, the second mutation, c.2896delA, is a rare mutation for which clinical presentation has not been described previously.

Keywords: I-cell disease; ML II; mucolipidosis II; secondary hyperparathyroidism.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Female
  • Gestational Age
  • Humans
  • Hyperparathyroidism, Secondary / complications
  • Hyperparathyroidism, Secondary / genetics
  • Hyperparathyroidism, Secondary / pathology*
  • Infant, Newborn
  • Mucolipidoses / complications
  • Mucolipidoses / genetics
  • Mucolipidoses / pathology*
  • Mutation
  • Prognosis
  • Transferases (Other Substituted Phosphate Groups) / genetics
  • Young Adult

Substances

  • Transferases (Other Substituted Phosphate Groups)
  • GNPTAB protein, human